Core Viewpoint - Guizhou Xintian Pharmaceutical Co., Ltd. has received a patent for a method to detect the fingerprint spectrum of ginkgo biloba decoction, which enhances its intellectual property protection and strengthens its core competitiveness through technological innovation [1][2]. Summary by Sections Patent Details - The patent is titled "A Method for Detecting the Fingerprint Spectrum of Ginkgo Biloba Decoction" with certificate number 8210031 [1]. - The patent was granted to Shanghai Shuo Fang Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the company [1]. - The patent application was filed on June 19, 2023, and the authorization announcement date is August 29, 2025 [1]. Technological Significance - The patented technology allows for comprehensive detection of the types and quantities of chemical components in ginkgo biloba, establishing a fingerprint spectrum method [1]. - This method will provide a basis for the use of high-quality medicinal materials in product production, ensuring product quality [1]. Impact on Company Operations - The acquisition of this patent is not expected to have a significant impact on the company's production and operations but will enhance the company's intellectual property protection system [2]. - The technology is anticipated to be utilized in the production of new drug products, improving the stability and effectiveness of the company's offerings [1][2].